Pharmacon Nuclear Inc - GA DeKalb, Atlanta 30340

Pharmacon Nuclear Inc entered the industry of Operators of Nonresidential Buildings in 1976 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 531312, which describes it as a Operators of Nonresidential Buildings. For further clarification, the SIC classifies this business under the code 6512 and described it as a Operators of Nonresidential Buildings. The business provides service to the B2B market.

To acquire more information, please contact Claude Tatro by calling (678) 209-0409 during business hours. You can also write to the business’ Single Location at 3812 Mcelroy Road, Atlanta, Georgia GA 30340. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Pharmacon Nuclear Inc
Representative: Claude Tatro
Place of Business: 3812 Mcelroy Road, Atlanta, GA 30340
Contact Number: (678) 209-0409
Type of Service: Operators of Nonresidential Buildings
SIC Number: 6512
NAICS Number: 531312
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 1976
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Pharmacon Nuclear Inc is a company operating from DeKalb, Georgia providing professional Operators of Nonresidential Buildings and relevant B2B variables. It was founded in 1976 and registered with the SIC code 6512 as Operators of Nonresidential Buildings, and with the NAICS code 531312 as Operators of Nonresidential Buildings.

With a current employee count of 1 to 4, Pharmacon Nuclear Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Claude Tatro at (678) 209-0409 for related queries, or to locate its Single Location using the coordinates 33.90317,-84.265831.

The Single Location can also be found at the street address 3812 Mcelroy Road in Atlanta, Georgia 30340 and can be engaged online through the company website at , the company Twitter , and Facebook page .